Literature DB >> 806676

Alteration in oxyhemoglobin equilibrium (P-50) and myocardial oxygen consumption (MVO2) by nitroglycerin (GTN).

G J Gross, H F Hardman.   

Abstract

In the isolated supported dog heart preparation perfused at a constant coronary blood flow, heart rate and left ventricular systolic pressure were not changed significantly by a 3-minute intracoronary infusion of nitroglycerin (5 and 10 mug/min). Nitroglycerin produced a significant increase in coronary venous pO2 and coronary venous P-50. These effects were accompanied by a significant decrease in myocardial oxygen consumption (MVO2). An infusion of dipyridamole (25 and 50 mug/min) did not produce significant changes in coronary venous pO2, P-50 or MVO2. Both drugs produced equivalent decreases in coronary artery perfusion pressure which suggests that the increase in coronary venous P-50 or reduction in MVO2 observed with nitroglycerin is not related to coronary vasodilation. The increase in P-50 induced by nitroglycerin was not accompanied by an increase in total erythrocytic 2,3-diphosphoglycerate and was not observed in vitro. The increase in P-50 produced by nitroglycerin provides a potential reservoir of readily diffusible oxygen that may be utilized during periods of myocardial hypoxia.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 806676

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  3 in total

1.  Pharmacodynamics of organic nitrates: concluding remarks.

Authors:  J B Osnes
Journal:  Drugs       Date:  1987       Impact factor: 9.546

2.  Preservation of canine myocardial high-energy phosphates during low-flow ischemia with modification of hemoglobin-oxygen affinity.

Authors:  R G Weiss; M A Mejia; D A Kass; A F DiPaula; L C Becker; G Gerstenblith; V P Chacko
Journal:  J Clin Invest       Date:  1999-03       Impact factor: 14.808

3.  Myocardial Energy Response to Glyceryl Trinitrate: Physiology Revisited.

Authors:  William D Watson; Peregrine G Green; Ladislav Valkovič; Neil Herring; Stefan Neubauer; Oliver J Rider
Journal:  Front Physiol       Date:  2021-12-31       Impact factor: 4.566

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.